HIPAA transaction standards, first put in place nearly a quarter of a century ago, might benefit from a re-examination and revamp to reflect changes in the healthcare industry. There is a push to simplify and improve the standards, says Stanley Nachimson, principal at Nachimson Advisors, a health information technology consultancy. The responsibility for doing so… Read More »
Print this page DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for Ravicti (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder… Read More »
May 2016, Kijabe, Kenya I arrived in casualty (the emergency department) to see a minimally responsive Kenyan boy with a body wasted from malnutrition. His mother stood at the bedside cradling his head, her eyes full of fear. His parents had traveled for days over rugged mountain roads in the rains to get to the… Read More »